Clinical trial
Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer
NCT00003236 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003236 |
|---|---|
| Title | Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer |
| Official title | Randomized Phase II Study of Human C-raf Kinase Antisense Oligonucleotide Isis 5132 (CGP 69846A) or Human Pkc-Alpha Antisence Oligonucleotide ISIS 3521 (CGP 64128A) in Women With Previously Treated Matastatic Breast Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug |
| Interventions | ISIS 3521, ISIS 5132 |
| Start date | Jul 13, 1998 |
| Primary completion | Jun 1, 2002 |
| First posted | Jun 9, 2004 |
| Last update posted | Jun 18, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: